CDKN2B-AS1 and chronic kidney disease: Recent data demonstrated that in patients starting on hemodialysis, ANRIL polymorphisms could identify risk of major adverse cardiovascular event [12] which indicated that ANRIL played an important role in CKD and was involved in the occurrence and development of cardiovascular complications in CKD.